Literature DB >> 12217722

Treatment of Staphylococcus epidermidis ventriculo-peritoneal shunt infection with linezolid.

C J Gill1, M A Murphy, D H Hamer.   

Abstract

Gram-positive bacterial meningitis frequently complicates ventriculo-peritoneal (VP) shunts used for hydrocephalus. Linezolid, an oxazolidinone, is active against Gram-positive cocci, and has excellent CSF penetration. We present a 22-year-old woman who was cured of a Staphylococcus epidermidis VP shunt infection via shunt removal and intravenous linezolid.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12217722     DOI： 10.1053/jinf.2002.0979

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


  8 in total

1.  Treatment of meningitis due to methicillin-resistant Staphylococcus epidermidis with linezolid.

Authors:  Wolfgang A Krueger; Bernd Kottler; Bernd E Will; Alexandra Heininger; Heinz Guggenberger; Klaus E Unertl
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 2.  Linezolid treatment of ventriculoperitoneal shunt infection without implant removal.

Authors:  P Castro; A Soriano; C Escrich; G Villalba; M Sarasa; J Mensa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-09       Impact factor: 3.267

3.  Action of linezolid or vancomycin on biofilms in ventriculoperitoneal shunts in vitro.

Authors:  Roger Bayston; Gautham Ullas; Waheed Ashraf
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

4.  Listeria monocytogenes: a rare complication of ventriculoperitoneal shunt in children.

Authors:  Alban Le Monnier; Stéphane Blanot; Eric Abachin; Jean-Luc Beretti; Patrick Berche; Samer Kayal
Journal:  J Clin Microbiol       Date:  2011-09-14       Impact factor: 5.948

5.  Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients.

Authors:  Pavlos Myrianthefs; Sophia L Markantonis; Konstantinos Vlachos; Maria Anagnostaki; Eleni Boutzouka; Dimitris Panidis; Georgios Baltopoulos
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

6.  2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis.

Authors:  Allan R Tunkel; Rodrigo Hasbun; Adarsh Bhimraj; Karin Byers; Sheldon L Kaplan; W Michael Scheld; Diederik van de Beek; Thomas P Bleck; Hugh J L Garton; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

7.  Early onset probable linezolid-induced encephalopathy.

Authors:  Jeffery Fletcher; Laura E Aykroyd; Eric C Feucht; James M Curtis
Journal:  J Neurol       Date:  2009-11-05       Impact factor: 4.849

8.  Intrathecal/Intraventricular Linezolid in Multidrug-Resistant Enterococcus faecalis Ventriculitis.

Authors:  Brian F Lich; Andrew K Conner; Joshua D Burks; Chad A Glenn; Michael E Sughrue
Journal:  J Neurol Surg Rep       Date:  2016-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.